Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Sep 30, 2016 $122.54 $122.54 $122.54 $122.54 1 892 700
Sep 29, 2016 $120.06 $120.06 $120.06 $120.06 1 976 400
Sep 28, 2016 $123.76 $123.76 $123.76 $123.76 1 384 100
Sep 27, 2016 $125.98 $125.98 $125.98 $125.98 1 350 900
Sep 26, 2016 $124.51 $124.51 $124.51 $124.51 1 484 700
Sep 23, 2016 $127.22 $127.22 $127.22 $127.22 2 154 600
Sep 22, 2016 $133.69 $133.69 $133.69 $133.69 1 175 600
Sep 21, 2016 $130.36 $130.36 $130.36 $130.36 1 210 400
Sep 20, 2016 $131.73 $131.73 $131.73 $131.73 1 136 900
Sep 19, 2016 $131.18 $131.18 $131.18 $131.18 1 240 100
Sep 16, 2016 $131.46 $131.46 $131.46 $131.46 2 930 200
Sep 15, 2016 $129.70 $129.70 $129.70 $129.70 1 574 000
Sep 14, 2016 $129.42 $129.42 $129.42 $129.42 968 200
Sep 13, 2016 $126.79 $126.79 $126.79 $126.79 1 169 100
Sep 12, 2016 $129.29 $129.29 $129.29 $129.29 1 227 700
Sep 09, 2016 $124.92 $124.92 $124.92 $124.92 1 550 300
Sep 08, 2016 $130.06 $130.06 $130.06 $130.06 2 071 100
Sep 07, 2016 $125.09 $125.09 $125.09 $125.09 915 400
Sep 06, 2016 $125.85 $125.85 $125.85 $125.85 1 394 100
Sep 02, 2016 $123.67 $123.67 $123.67 $123.67 1 083 000
Sep 01, 2016 $125.63 $125.63 $125.63 $125.63 1 335 700
Aug 31, 2016 $125.86 $125.86 $125.86 $125.86 1 371 400
Aug 30, 2016 $128.22 $128.22 $128.22 $128.22 823 700
Aug 29, 2016 $127.99 $127.99 $127.99 $127.99 955 600
Aug 26, 2016 $129.63 $129.63 $129.63 $129.63 1 057 800
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT